DAEWOONGPHARMACEUTICAL Stock Price & Chart

KRX: 069620 · 대웅제약 · KOSPI

₩111,900 ₩1,300 (-1.15%)at close · September 11, 2026
199,400105,000111,900Aug 20, 25Nov 26Mar 06Jun 10Sep 11, 26

DAEWOONGPHARMACEUTICAL (대웅제약, KRX: 069620) last closed at ₩111,900 on September 11, 2026, a -1.15% move on the day. Over the trailing 52 weeks the stock has traded between ₩105,000 and ₩199,400, a -17.48% change over the past year. Figures are end-of-day closing prices from the Korea Exchange.

Last close₩111,900
Day change-1.15%
52-week high₩199,400
52-week low₩105,000

Key Fundamentals

FY 2026.06
Market cap₩1.30T
P/E (PER)6.62
P/B (PBR)1.28
EPS₩16,904
BPS₩87,439
ROE20.62%
Debt ratio112.98%
Rev. growth8.44%

P/E, P/B and market cap are computed from the latest close; EPS, BPS, ROE and debt ratio are the most recent reported figures (FY 2026.06) from the Korea Investment & Securities Open API. Informational only, not investment advice.

Analyst Consensus

7 ratings · last Jul 30, 2026
Buy7
Hold0
Sell0
Avg. target₩191,429
Upside+71.1%
High₩220,000
Low₩170,000
BrokerageRatingTargetDate
Hyundai Motor SecuritiesBuy₩180,000Jul 30, 2026
iM SecuritiesBuy₩180,000Jul 30, 2026
Kiwoom SecuritiesBuy₩170,000Jul 30, 2026
Samsung SecuritiesBuy₩180,000Jul 29, 2026
Daol Investment & SecuritiesBuy₩220,000Jul 3, 2026
KB SecuritiesBuy₩210,000May 27, 2026
Mirae Asset SecuritiesBuy₩200,000May 14, 2026

Latest published rating and 12-month target price per brokerage over the past 180 days, via the Korea Investment & Securities Open API. Each house is counted once at its most recent view; averages exclude unrated notes. This summarises what analysts have published — it is not a recommendation, and not investment advice.

Technical Snapshot

as of 2026-09-11
BearishAlgorithmic summary of 5 standard indicators (net score -5). Describes current technical posture only — not a buy or sell recommendation.
  • ▼ Bearish20-day MAPrice below 120,540
  • ▼ Bearish60-day MAPrice below 122,223
  • ▼ Bearish120-day MAPrice below 132,635
  • ▼ BearishMA trend (20 vs 60)Short-term below mid-term
  • · NeutralRSI (14)RSI 32 — neutral zone
  • ▼ BearishMACD (12,26,9)MACD below signal
52-week position: 7% of rangeRSI(14): 325-day volume vs 20-day: -33%

Indicators are computed mechanically from end-of-day prices. They are provided for informational purposes only, are not investment advice or a recommendation, and past performance does not indicate future results.

No daily reports have covered DAEWOONGPHARMACEUTICAL yet. New reports appear here automatically when the stock is featured.

← Back to all Korean stocks

Price history is sourced from the Korea Exchange via the Korea Investment & Securities Open API and updated after each trading session. This page is provided for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data may be delayed or contain errors — verify with an official source before trading.